Quick answer
Idexx Laboratories Inc /De (IDXX) reported revenue of $4.30B and net income of $1.06B for the fiscal year ended 2025-12-31, up 10.4% from $3.90B the year before, per its 10-K filed with the SEC on 2026-02-20. Long-term debt stood at $450.0M.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $4.30B | $1.06B | $450.0M |
| 2024 (FY ending 2024-12-31) | $3.90B | $887.9M | $617.8M |
| 2023 (FY ending 2023-12-31) | $3.66B | $845.0M | $698.2M |
| 2022 (FY ending 2022-12-31) | $3.37B | $679.1M | $769.8M |
| 2021 (FY ending 2021-12-31) | $3.22B | $744.8M | $850.7M |
| 2020 (FY ending 2020-12-31) | $2.71B | $581.8M | $909.1M |
| 2019 (FY ending 2019-12-31) | $2.41B | $427.7M | $699.4M |
| 2018 (FY ending 2018-12-31) | $2.21B | $377.0M | $601.8M |
| 2017 (FY ending 2017-12-31) | $1.97B | $263.1M | $606.6M |
| 2016 (FY ending 2016-12-31) | $1.78B | $222.0M | $593.7M |
Related
- ICE revenue, net income and debt history (Intercontinental Exchange, Inc.)
- IDA revenue, net income and debt history (Idacorp Inc)
- IDCC revenue, net income and debt history (Interdigital, Inc.)
- IESC revenue, net income and debt history (IES Holdings, Inc.)
- IEX revenue, net income and debt history (Idex Corp)
- ILMN revenue, net income and debt history (Illumina, Inc.)
- INCY revenue, net income and debt history (Incyte Corporation)
- INSM revenue, net income and debt history (Insmed Inc)
Last updated 2026-10-16. Data only, not financial or tax advice.